Sign in

CIK 0001819790 · Large accelerated filer

Tarsus Pharmaceuticals, Inc.

Sign in to watch
Ticker
TARS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
814717861
Phone
(949) 409-9820
Business address
15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
  1. S-8 Other Securities Offered to Employees in Benefit Plans
  2. 8-K Event Bylaws or fiscal year change
  3. 424B4 Offering Prospectus
  4. EFFECT Other Notice of Effectiveness
  5. S-1MEF Other S-1MEF
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. CERT Other Certification
  20. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit

Page 33 of 34 · 676 filings